PLURI Trademark

Trademark Overview


On Sunday, November 19, 2023, a trademark application was filed for PLURI with the United States Patent and Trademark Office. The USPTO has given the PLURI trademark a serial number of 79397427. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, May 19, 2025. This trademark is owned by PLURI BIOTECH LTD. The PLURI trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Cells, their extracts and components and biological preparations intended for medical and clinical use for the treatment of cardiovascular diseases, Critical Limb Ischemia (CLI), muscle regeneration, Acute Radiation Syndrome (ARS), Delayed Effects of Acute Radiation Exposure (DEARE), hematological deficiencies, and pathogenic infectious; bioengineered cells and bioengineered tissue for medical and clinical use for the treatment of cancer; bioengineered cells for use in immunotherapies for treatment of cancer (solid tumors), pathogenic infectious diseases; bioengineered human T cells for medical and clinical use; human cells from placentas for medical and clinical use; dietary supplements based on human cells from placentas for cosmetic and aesthetic use; dietary supplements and medical preparations based on human cells from placentas for use in prevention of hair loss; isolated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and c...

Biological preparations for use in industry and science; bioengineered cells for use in industry and science; bioengineered human T cells for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in the manufacture of cosmetic and aesthetic products; biological tissue, namely, human and animal cells from placentas for use in manufacturing biological cosmetic preparations for prevention of hair loss; isolated plant cells, their extracts, and components being botanical extracts, other than essential oils, for use in industry and science; biological tissue, namely, isolated and cultivated adherent cells from placenta tissue for use industry and science; biological tissue, namely, isolated and cultivated adherent stromal cells derived from placentas of multiple donors for use in industry and science; biological tissue, namely, isolated and cultiv...

Scientific and technological services, namely, scientific research relating to isolation and culturing of animal cells and plant cells and to animal and plant tissues isolation and culturing, to biological preparations intended for medical, clinical, and scientific use of cultured cells and their extracts, to bioengineered cells and tissues, to bioengineered cells for use in immunotherapy for cancer and other infectious diseases, to bioengineered human T cells, to isolated and cultivated human and animal placentas cells, to isolated plant cells and their extracts, to isolated and cultivated adherent cells from placenta tissue, to isolated and cultivated adherent stromal cells derived from placentas of multiple donors, to isolated and cultivated mammal cells, their extracts and preparations containing them, to isolated and cultivated fish cells and sea food cells and preparations containing the same, to isolated and cultivated plant cells and their extracts and preparations containing t...
pluri

General Information


Serial Number79397427
Word MarkPLURI
Filing DateSunday, November 19, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, May 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized word "PLURI", with the "P" and the "I" each having a shaded circle above them with a curved line extending between the circles.
Goods and ServicesCells, their extracts and components and biological preparations intended for medical and clinical use for the treatment of cardiovascular diseases, Critical Limb Ischemia (CLI), muscle regeneration, Acute Radiation Syndrome (ARS), Delayed Effects of Acute Radiation Exposure (DEARE), hematological deficiencies, and pathogenic infectious; bioengineered cells and bioengineered tissue for medical and clinical use for the treatment of cancer; bioengineered cells for use in immunotherapies for treatment of cancer (solid tumors), pathogenic infectious diseases; bioengineered human T cells for medical and clinical use; human cells from placentas for medical and clinical use; dietary supplements based on human cells from placentas for cosmetic and aesthetic use; dietary supplements and medical preparations based on human cells from placentas for use in prevention of hair loss; isolated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and clinical use; isolated and cultivated adherent cells from placenta tissue for medical and clinical use; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for medical and clinical use; ; isolated and cultivated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and clinical use and preparations containing the same for the treatment of inflammatory skin conditions, skin regeneration following burns and/or environmental damage, wound healing, anti-inflammatory processes (e.g., arthritis), maintaining and supporting gut health, boost immunity, and improve general energy levels.
Goods and ServicesBiological preparations for use in industry and science; bioengineered cells for use in industry and science; bioengineered human T cells for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in the manufacture of cosmetic and aesthetic products; biological tissue, namely, human and animal cells from placentas for use in manufacturing biological cosmetic preparations for prevention of hair loss; isolated plant cells, their extracts, and components being botanical extracts, other than essential oils, for use in industry and science; biological tissue, namely, isolated and cultivated adherent cells from placenta tissue for use industry and science; biological tissue, namely, isolated and cultivated adherent stromal cells derived from placentas of multiple donors for use in industry and science; biological tissue, namely, isolated and cultivated mammal cells, their extracts and components for use in industrial manufacture of foodstuffs; biological tissue, namely, isolated and cultivated fish cells and sea food being marine animal cells for use in industrial manufacture of foodstuffs; biological tissue, namely, isolated and cultivated plant cells and their extracts, other than essential oils, for use in industrial manufacture of foodstuffs
Goods and ServicesScientific and technological services, namely, scientific research relating to isolation and culturing of animal cells and plant cells and to animal and plant tissues isolation and culturing, to biological preparations intended for medical, clinical, and scientific use of cultured cells and their extracts, to bioengineered cells and tissues, to bioengineered cells for use in immunotherapy for cancer and other infectious diseases, to bioengineered human T cells, to isolated and cultivated human and animal placentas cells, to isolated plant cells and their extracts, to isolated and cultivated adherent cells from placenta tissue, to isolated and cultivated adherent stromal cells derived from placentas of multiple donors, to isolated and cultivated mammal cells, their extracts and preparations containing them, to isolated and cultivated fish cells and sea food cells and preparations containing the same, to isolated and cultivated plant cells and their extracts and preparations containing the same, to research, development and testing services in the fields of mass production of animal and plant cells, and to research, development and testing services in the fields of large scale production of various cells in bioreactors

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePLURI BIOTECH LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIL

Trademark Events


Event DateEvent Description
Thursday, June 13, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, June 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2024APPLICATION FILING RECEIPT MAILED
Monday, June 24, 2024ASSIGNED TO EXAMINER
Monday, July 1, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 2, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 29, 2024REFUSAL PROCESSED BY MPU
Tuesday, July 30, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, August 18, 2024REFUSAL PROCESSED BY IB
Wednesday, February 12, 2025ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, February 12, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, April 14, 2025PETITION TO REVIVE-GRANTED
Monday, April 14, 2025NOTICE OF REVIVAL - E-MAILED
Monday, April 14, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 19, 2025SUSPENSION LETTER WRITTEN
Monday, May 19, 2025LETTER OF SUSPENSION E-MAILED
Monday, May 19, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED